Individuals with CHIP have a higher risk of developing a myeloid neoplasm, but are also at higher risk of developing cardiovascular diseases, type 2 diabetes, or second cancer and have a higher all-cause mortality [105,107,111,119]. The gene discussed is STUB1; the disease is type 2 diabetes mellitus.